Attending Oracle Health Conference? Connect with us while you’re there to learn more about optimizing patient-centric clinical trials with best-in-class digital tools that drive efficiency and improve data quality to generate stronger evidence.
Join hybrid clinical trial experts from ObvioHealth and Oracle as they discuss:
Scott has spent over 25 years bringing integrated commercial and operational planning expertise to life science, pharmaceutical, and healthcare software companies—including Flywheel, Suvoda, Clario, and Oracle. Scott’s results-driven mindset is leading ObvioHealth’s commercial team in the successful global rollout of its next-generation DCT platform and app, ObvioGo®.
Florence Mowlem, PhD, is an expert eCOA scientist who has spent her career advising and guiding clinical research organizations—including industry powerhouses Medable and Signant Health. At ObvioHealth, Florence will apply her eCOA experience and years of research to further advance the use of health devices in clinical trials and to support the needs of trial participant.
David Blackman is an experienced digital trials strategist who has spent 20 years leading and incubating cutting-edge solutions for massive technology organizations, including IBM, Lenovo, and PPD. At Oracle, David is responsible for developing differentiating technology and business capabilities that enhance clinical trial research and bring drugs to market faster for Oracle’s clients.
ObvioHealth is a global virtual research organization (VRO) combining the clinical excellence of the best CROs with a pioneering digital health platform to deliver stronger evidence to sites and sponsors. Our tech-enabled team optimizes clinical trials at every touchpoint with a unique combination of three capabilities: